Explore
Validate
LearnHPA001292
antibody from Atlas Antibodies
Targeting: SERPINA1
A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA001292 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA001292, RRID:AB_1844762
- Product name
- Anti-SERPINA1
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human SERPINA1, Gene description: serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1, Alternative Gene Names: A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1, Validated applications: IHC, ICC, WB, Uniprot ID: P01009, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.2 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references The association of tumor-expressed REG4, SPINK4 and alpha-1 antitrypsin with cancer-associated thrombosis in colorectal cancer
Systemic modified messenger RNA for replacement therapy in alpha 1-antitrypsin deficiency.
A High-throughput Bead-based Affinity Assay Enables Analysis of Genital Protein Signatures in Women At Risk of HIV Infection
SERPINA1 mRNA as a Treatment for Alpha-1 Antitrypsin Deficiency
Tumour expression of bladder cancer‐associated urinary proteins
Buijs J, van Beijnum R, Anijs R, Laghmani E, Sensuk L, Minderhoud C, Ünlü B, Klok F, Kuppen P, Cannegieter S, Versteeg H
Journal of Thrombosis and Thrombolysis 2023;57(3):370-380
Journal of Thrombosis and Thrombolysis 2023;57(3):370-380
Systemic modified messenger RNA for replacement therapy in alpha 1-antitrypsin deficiency.
Karadagi A, Cavedon AG, Zemack H, Nowak G, Eybye ME, Zhu X, Guadagnin E, White RA, Rice LM, Frassetto AL, Strom S, Jorns C, Martini PGV, Ellis E
Scientific reports 2020 Apr 27;10(1):7052
Scientific reports 2020 Apr 27;10(1):7052
A High-throughput Bead-based Affinity Assay Enables Analysis of Genital Protein Signatures in Women At Risk of HIV Infection
Månberg A, Bradley F, Qundos U, Guthrie B, Birse K, Noël-Romas L, Lindskog C, Bosire R, Kiarie J, Farquhar C, Burgener A, Nilsson P, Broliden K
Molecular & Cellular Proteomics 2019;18(3):461-476
Molecular & Cellular Proteomics 2019;18(3):461-476
SERPINA1 mRNA as a Treatment for Alpha-1 Antitrypsin Deficiency
Connolly B, Isaacs C, Cheng L, Asrani K, Subramanian R
Journal of Nucleic Acids 2018;2018
Journal of Nucleic Acids 2018;2018
Tumour expression of bladder cancer‐associated urinary proteins
Lindén M, Segersten U, Runeson M, Wester K, Busch C, Pettersson U, Lind S, Malmström P
BJU International 2013;112(3):407-415
BJU International 2013;112(3):407-415
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human kidney and cerebral cortex tissues using HPA001292 antibody. Corresponding SERPINA1 RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol
